AstraZeneca & Pangaea Partner to Advance AI-Powered Precision Healthcare

Microsoft & NVIDIA Documentary: Pangaea Data Closing Care Gaps

Pangaea Data enters AI collaboration with Alexion to help improve detection of HPP in adults

Pangaea Data Secures Strategic Investment from Topcon Healthcare to Close Care Gaps in Eye Care

GO BACK

Characterizing Patients Across Hard-to-Diagnose Conditions in a Privacy-Preserving & Scalable Manner

Clinicians spend more than 35% of their time capturing patient data, symptoms, family histories, lab results and such key information in the form of digitized patient records. In spite of this, more than 60% of patients with rare and hard-to-diagnose conditions are not diagnosed in a timely manner. This is due to lack of scalable and speedy access to actionable intelligence from such records, which is required by clinicians to map patient journeys.

This short Q&A style blog discusses how Pangaea’s AI-driven product, PIES (Pangaea’s Intelligence Extraction and Summarization), is improving patient outcomes through characterization of patients and mapping their journey across hard-to-diagnose conditions by discovering clinically actionable intelligence from their records in a scalable, evolving and privacy-preserving manner. This has proven to be critical for finding more miscoded, misdiagnosed, undiagnosed and at-risk patients in the context of precision medicine, preventative health and clinical trials.

Request Whitepaper